Antibiotic API Market

Antibiotics refer to a class of secondary metabolites with anti-pathogen or other activities produced by bacteria, fungi and other microorganisms or higher animals and plants during their lives. They are chemical substances that can interfere with the development of other living cells. Commonly used clinical antibiotics include extracts from microbial cultures and chemically synthesized or semi-synthetic compounds. Antibiotic API Market only counts antibiotic raw materials, excluding various intermediates and penicillin industrial salts.

Antibiotic API Market contains market size and forecasts of Antibiotic API in global, including the following market information:

Global Antibiotic API Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antibiotic API Market Sales, 2017-2022, 2023-2028, (Tons)

Global top five Antibiotic API companies in 2021 (%)

The global Antibiotic API market was valued at 5595.3 million in 2021 and is projected to reach US$ 5125.9 million by 2028, at a CAGR of -1.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Penicillins Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibiotic API include UNITED LABORATORIES, North China Pharmaceutical, RUIYING PIONEER PHARMACEUTICAL, Centrient Pharmaceuticals, Aurobindo Pharma, Shyndec Pharmaceutical, Nectar Lifesciences, Harbin Pharmaceutical Group and ACS Dobfar, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antibiotic API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibiotic API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antibiotic API Market Segment Percentages, by Type, 2021 (%)

Penicillins

Cephalosporins

Aminoglycosides

Tetracyclines

Quinolones

Macrolides

Lincomycins

Others

Global Antibiotic API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antibiotic API Market Segment Percentages, by Application, 2021 (%)

Oral Medicine

Injection Medicine

Global Antibiotic API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Antibiotic API Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibiotic API revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antibiotic API revenues share in global market, 2021 (%)

Key companies Antibiotic API sales in global market, 2017-2022 (Estimated), (Tons)

Key companies Antibiotic API sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

UNITED LABORATORIES

North China Pharmaceutical

RUIYING PIONEER PHARMACEUTICAL

Centrient Pharmaceuticals

Aurobindo Pharma

Shyndec Pharmaceutical

Nectar Lifesciences

Harbin Pharmaceutical Group

ACS Dobfar

Novartis

CSPC

QILU ANTIBIOTICS PHARMACEUTICAL

REYOUNG

Orchid Pharma

FUAN PHARMACEUTICAL

Dongying Pharmaceutical

FUKANG PHARMACEUTICAL

Medya Pharmaceutical

LUKANG PHARMACEUTICAL

Dawnrays Pharmaceutical

SALUBRIS

KELUN

HUAFANG PHARMACEUTICAL